denkapparat Operations GmbH Invests $297,000 in Amdocs Limited $DOX

denkapparat Operations GmbH bought a new stake in shares of Amdocs Limited (NASDAQ:DOX) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 3,256 shares of the technology company’s stock, valued at approximately $297,000.

Other institutional investors also recently added to or reduced their stakes in the company. Quarry LP boosted its position in Amdocs by 42.2% in the 1st quarter. Quarry LP now owns 391 shares of the technology company’s stock valued at $36,000 after buying an additional 116 shares during the period. Alhambra Investment Management LLC increased its position in shares of Amdocs by 5.0% during the second quarter. Alhambra Investment Management LLC now owns 2,585 shares of the technology company’s stock worth $236,000 after acquiring an additional 124 shares during the period. William Blair Investment Management LLC raised its stake in shares of Amdocs by 2.4% during the second quarter. William Blair Investment Management LLC now owns 5,650 shares of the technology company’s stock valued at $516,000 after acquiring an additional 133 shares in the last quarter. Mutual Advisors LLC boosted its holdings in shares of Amdocs by 3.2% in the second quarter. Mutual Advisors LLC now owns 4,516 shares of the technology company’s stock valued at $397,000 after purchasing an additional 138 shares during the period. Finally, MGO One Seven LLC boosted its holdings in shares of Amdocs by 5.1% in the second quarter. MGO One Seven LLC now owns 2,899 shares of the technology company’s stock valued at $264,000 after purchasing an additional 140 shares during the period. Hedge funds and other institutional investors own 92.02% of the company’s stock.

Amdocs Stock Down 7.9%

Shares of Amdocs stock opened at $77.36 on Thursday. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.23. The company has a market cap of $8.73 billion, a P/E ratio of 15.69, a PEG ratio of 1.40 and a beta of 0.51. The firm’s 50 day moving average price is $83.34 and its 200-day moving average price is $87.41. Amdocs Limited has a 52-week low of $76.50 and a 52-week high of $95.41.

Amdocs (NASDAQ:DOX) last posted its earnings results on Tuesday, November 11th. The technology company reported $1.83 EPS for the quarter, beating analysts’ consensus estimates of $1.82 by $0.01. Amdocs had a net margin of 11.94% and a return on equity of 19.66%. The company had revenue of $1.15 billion during the quarter, compared to analysts’ expectations of $1.15 billion. During the same quarter in the prior year, the company posted $1.70 earnings per share. Amdocs’s revenue for the quarter was down 9.0% compared to the same quarter last year. Amdocs has set its FY 2026 guidance at 7.270-7.550 EPS. Q1 2026 guidance at 1.730-1.790 EPS. On average, sell-side analysts predict that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Wednesday, December 31st will be paid a dividend of $0.527 per share. This represents a $2.11 annualized dividend and a yield of 2.7%. The ex-dividend date is Wednesday, December 31st. Amdocs’s payout ratio is 42.60%.

Analyst Ratings Changes

DOX has been the topic of several research reports. Bank of America reduced their price objective on Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a report on Wednesday. Weiss Ratings restated a “hold (c)” rating on shares of Amdocs in a research note on Thursday, October 30th. Stifel Nicolaus lowered their price objective on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research note on Wednesday. Finally, Wall Street Zen cut shares of Amdocs from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Four research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $101.67.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.